Adherence of systematic reviews to Cochrane RoB2 guidance was frequently poor: a meta epidemiological study-Reference-Cited by-同舟云学术

Adherence of systematic reviews to Cochrane RoB2 guidance was frequently poor: a meta epidemiological study

Published:2022-12 Issue: Volume:152 Page:47-55
ISSN:0895-4356
Container-title:Journal of Clinical Epidemiology
language:en
Short-container-title:Journal of Clinical Epidemiology

Author:

Minozzi Silvia,Gonzalez-Lorenzo Marien,Cinquini Michela,Berardinelli Daniela^ORCID,Cagnazzo Celeste,Ciardullo Stefano^ORCID,De Nardi Paola^ORCID,Gammone Mariarosaria^ORCID,Iovino Paolo,Lando Alex^ORCID,Rissone Marco,Simeone Giovanni,Stracuzzi Marta^ORCID,Venezia Giovanna^ORCID,Moja Lorenzo,Costantino Giorgio,Cianciulli Angelo,Cinnirella Andrea,Grosso Francesca,Luceri Francesco,Venuti Giuseppe,Vultaggio Stefania,Zambarbieri Emiliano

Publisher

Elsevier BV

Subject

Epidemiology

Reference26 articles.

1. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables;Guyatt;J Clin Epidemiol,2011

2. Empirical evidence of study design biases in randomized trials: systematic review of meta-epidemiological studies;Page;PLoS One,2016

3. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials;Higgins;BMJ,2011

4. Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews;Jørgensen;Syst Rev,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommitting to Rules of Evidence and Laws of Inference;The Journal of Pediatrics;2024-12

2. Effectiveness of dexmedetomidine on patient-centred outcomes in surgical patients: a systematic review and Bayesian meta-analysis;British Journal of Anaesthesia;2024-09

3. Zero‐ and few‐shot prompting of generative large language models provides weak assessment of risk of bias in clinical trials;Research Synthesis Methods;2024-08-23

4. Research Quality of Clinical Trials Reported for Foods with Function Claims in Japan, 2023–2024: Evaluation Based on a Revised Tool to Assess Risk of Bias in Randomized Trials;Nutrients;2024-08-17

5. Polatuzumab vedotin combined with bendamustine and rituximab for relapsed/refractory diffuse large B-cell lymphoma: A systematic review protocol;PLOS ONE;2024-08-01